Article Information
History
- May 23, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Carlo Cervia1,†,
- Jakob Nilsson1,†,
- Yves Zurbuchen1,
- Alan Valaperti1,
- Jens Schreiner1,
- Aline Wolfensberger2,
- Miro E. Raeber1,
- Sarah Adamo1,
- Marc Emmenegger3,
- Sara Hasler1,
- Philipp P. Bosshard4,
- Elena De Cecco3,
- Esther Bächli5,
- Alain Rudiger6,
- Melina Stüssi-Helbling7,
- Lars C. Huber7,
- Annelies S. Zinkernagel2,
- Dominik J. Schaer8,
- Adriano Aguzzi3,
- Ulrike Held9,
- Elsbeth Probst-Müller1,
- Silvana K. Rampini2 and
- Onur Boyman1,10,*
- 1Department of Immunology, University Hospital Zurich (USZ), Zurich, Switzerland
- 2Department of Infectious Diseases and Hospital Epidemiology, USZ, Zurich, Switzerland
- 3Institute of Neuropathology, USZ, Zurich, Switzerland
- 4Department of Dermatology, USZ, Zurich, Switzerland
- 5Clinic for Internal Medicine, Uster Hospital, Uster, Switzerland
- 6Department of Medicine, Limmattal Hospital, Schlieren, Switzerland
- 7Clinic for Internal Medicine, City Hospital Triemli Zurich, Zurich, Switzerland
- 8Department of Internal Medicine, USZ, Zurich, Switzerland
- 9Department of Biostatistics, at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland
- 10Faculty of Medicine, University of Zurich, Zurich, Switzerland
- ↵*Corresponding author: Onur Boyman, MD, Department of Immunology, University Hospital Zurich (USZ), Gloriastrasse 23, 8091 Zurich, Switzerland. E-mail: onur.boyman{at}uzh.ch; phone: +41 44 255 2069.
↵† Contributed equally
Posted May 23, 2020.
Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19
